Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nīmes
With
University Hospital, Limoges
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Need to perform colorectal cancer screening colonoscopy:
* Primary Screening: Fecal Immunological Test positive;
* Secondary screening: personal or family history of polyps, personal or family history of colorectal cancer, rectorrhagia-like symptomatology.
Patient candidate for outpatient management.
Patient who has given free and informed consent.
Patient who has signed the consent form.
Patient affiliated or beneficiary of a health insurance plan.
You may not be if
The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
The subject refuses to sign the consent
It is impossible to give the subject informed information
The patient is under safeguard of justice or state guardianship
History of inflammatory bowel disease, Crohn's disease.
Failure of a previous colonoscopy.
Known familial polyposis.
Contraindication to polypectomy (coagulation disorder, treatment with CLOPIDOGREL / anticoagulant).
Clareo Health | Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
